ABCL – AbCellera Biologics Inc.
[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=ABCL
#%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=ABCL
&conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]
Float Short %
21.32
Margin Of Safety %
Put/Call OI Ratio
0.18
EPS Next Q Diff
0.01
EPS Last/This Y
-0.1
EPS This/Next Y
0.02
Price
3.04
Target Price
9.83
Analyst Recom
1.25
Performance Q
-16.94
Upside
-767.8%
Beta
0.86
Ticker: ABCL
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-23 | ABCL | 4.24 | 0.14 | 0.12 | 69282 |
| 2026-01-26 | ABCL | 4.13 | 0.15 | 0.29 | 70329 |
| 2026-01-27 | ABCL | 4 | 0.16 | 0.62 | 71281 |
| 2026-01-28 | ABCL | 3.9 | 0.16 | 0.16 | 71717 |
| 2026-01-29 | ABCL | 3.87 | 0.16 | 1.44 | 71926 |
| 2026-01-30 | ABCL | 3.62 | 0.18 | 0.21 | 72879 |
| 2026-02-02 | ABCL | 3.51 | 0.17 | 0.22 | 73895 |
| 2026-02-03 | ABCL | 3.5 | 0.18 | 0.74 | 73874 |
| 2026-02-04 | ABCL | 3.26 | 0.18 | 0.08 | 74279 |
| 2026-02-05 | ABCL | 2.79 | 0.18 | 0.23 | 74236 |
| 2026-02-06 | ABCL | 3.15 | 0.20 | 0.36 | 71286 |
| 2026-02-09 | ABCL | 3.22 | 0.19 | 0.25 | 73091 |
| 2026-02-10 | ABCL | 3.16 | 0.19 | 0.73 | 73209 |
| 2026-02-11 | ABCL | 3.13 | 0.19 | 4.26 | 73487 |
| 2026-02-12 | ABCL | 2.94 | 0.20 | 3.21 | 73901 |
| 2026-02-13 | ABCL | 3.12 | 0.20 | 1.52 | 73905 |
| 2026-02-17 | ABCL | 3.16 | 0.20 | 0.40 | 73864 |
| 2026-02-18 | ABCL | 3.12 | 0.20 | 0.13 | 74232 |
| 2026-02-19 | ABCL | 3.23 | 0.18 | 0.20 | 72974 |
| 2026-02-20 | ABCL | 3.05 | 0.18 | 0.72 | 73085 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-01-23 | ABCL | 4.24 | -58.3 | - | -0.65 |
| 2026-01-26 | ABCL | 4.14 | -58.3 | - | -0.65 |
| 2026-01-27 | ABCL | 3.99 | -58.3 | - | -0.65 |
| 2026-01-28 | ABCL | 3.90 | -58.3 | - | -0.65 |
| 2026-01-29 | ABCL | 3.87 | -58.3 | - | -0.65 |
| 2026-01-30 | ABCL | 3.62 | -58.3 | - | -0.65 |
| 2026-02-02 | ABCL | 3.51 | -58.3 | - | -0.65 |
| 2026-02-03 | ABCL | 3.52 | -58.3 | - | -0.65 |
| 2026-02-04 | ABCL | 3.27 | -58.3 | - | -0.65 |
| 2026-02-05 | ABCL | 2.79 | -58.3 | - | -0.65 |
| 2026-02-06 | ABCL | 3.16 | -58.3 | - | -0.65 |
| 2026-02-09 | ABCL | 3.22 | -58.3 | - | -0.65 |
| 2026-02-10 | ABCL | 3.17 | -58.3 | - | -0.65 |
| 2026-02-11 | ABCL | 3.14 | -58.3 | - | -0.65 |
| 2026-02-12 | ABCL | 2.94 | -58.3 | - | -0.65 |
| 2026-02-13 | ABCL | 3.12 | -58.3 | - | -0.65 |
| 2026-02-17 | ABCL | 3.16 | -58.3 | - | -0.65 |
| 2026-02-18 | ABCL | 3.13 | -58.3 | - | -0.65 |
| 2026-02-19 | ABCL | 3.23 | -58.3 | - | -0.65 |
| 2026-02-20 | ABCL | 3.04 | -50.0 | - | -0.65 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-23 | ABCL | 0.00 | -1.80 | 21.00 |
| 2026-01-26 | ABCL | 0.00 | -1.95 | 21.00 |
| 2026-01-27 | ABCL | 0.00 | -1.95 | 21.00 |
| 2026-01-28 | ABCL | 0.00 | -1.95 | 20.45 |
| 2026-01-29 | ABCL | 0.00 | -1.95 | 20.45 |
| 2026-01-30 | ABCL | 0.00 | -1.95 | 20.45 |
| 2026-02-02 | ABCL | 0.00 | -8.33 | 20.45 |
| 2026-02-03 | ABCL | 0.00 | -8.33 | 20.45 |
| 2026-02-04 | ABCL | 0.00 | -8.33 | 20.45 |
| 2026-02-05 | ABCL | 0.00 | -8.33 | 20.45 |
| 2026-02-06 | ABCL | 0.00 | -8.33 | 20.45 |
| 2026-02-09 | ABCL | 0.00 | -4.28 | 20.45 |
| 2026-02-10 | ABCL | 0.00 | -4.28 | 20.45 |
| 2026-02-11 | ABCL | 0.00 | -4.28 | 21.28 |
| 2026-02-12 | ABCL | 0.00 | -4.28 | 21.28 |
| 2026-02-13 | ABCL | 0.00 | -4.28 | 21.28 |
| 2026-02-17 | ABCL | 0.00 | 0.20 | 21.29 |
| 2026-02-18 | ABCL | 0.00 | 0.20 | 21.29 |
| 2026-02-19 | ABCL | 0.00 | 0.20 | 21.29 |
| 2026-02-20 | ABCL | 0.00 | 0.20 | 21.32 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=ABCL
589 360 ]
Last Quarter Act. EPS
-0.19
Avg. EPS Est. Current Quarter
-0.19
Avg. EPS Est. Next Quarter
-0.18
Insider Transactions
Institutional Transactions
0.2
Beta
0.86
Average Sales Estimate Current Quarter
6
Average Sales Estimate Next Quarter
16
Fair Value
Quality Score
21
Growth Score
35
Sentiment Score
43
Actual DrawDown %
93.2
Max Drawdown 5-Year %
-95.6
Target Price
9.83
P/E
Forward P/E
PEG
P/S
25.76
P/B
0.94
P/Free Cash Flow
EPS
-0.58
Average EPS Est. Cur. Y
-0.65
EPS Next Y. (Est.)
-0.63
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-486.01
Relative Volume
1.12
Return on Equity vs Sector %
-46.8
Return on Equity vs Industry %
-29.3
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.05
EBIT Estimation
[iframe https://widget.finnhub.io/widgets/recommendation?symbol=ABCL
589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=ABCL
589 450 ]
AbCellera Biologics Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 596
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
stock quote shares ABCL – AbCellera Biologics Inc. Stock Price stock today
news today ABCL – AbCellera Biologics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ABCL – AbCellera Biologics Inc. yahoo finance google finance
stock history ABCL – AbCellera Biologics Inc. invest stock market
stock prices ABCL
premarket after hours
ticker ABCL
fair value insiders trading